


First Investment: 2021
Finding new drugs to treat disease requires understanding the exact changes in gene and protein expression that make patients sick. Relation Therapeutics is using active graph machine learning, a mathematical method adapted from consumer social networking, to study data from individual human cells to find the most promising ways to treat disease, starting with osteoporosis.
News & Insights

Deep Tech Opportunities Report

News
Relation Therapeutics partners with GSK in history-making collaboration to create new treatments for fibrosis and osteoarthritis

Deep Tech Opportunities Report
DCVC DTOR 2024: In the AI race, data will emerge as the critical asset

News
DCVC leads $35 million financing to help UK TechBio leader Relation Therapeutics to seek new treatments for complex diseases
In The Media
Endpoints News
'It's the biology, stupid': Relation and GSK team up on fibrosis, osteoarthritis
Relation
Endpoints News
‘ChatGPT for DNA’: Relation nabs $35M, with Nvidia backing, for osteoporosis work
Relation
Clarivate
Seven AI/ML for Life Sciences Companies Identified as Innovators in New Clarivate Companies to Watch Report
Relation
Explore Companies

Grove Biopharma
Putting protein-like drugs inside cells to fight cancer and neurodegeneration

Syntax Bio
Programming stem cells to differentiate into desired cell types, faster

Fable Therapeutics
Using state-of-the-art machine learning models to create custom-build protein drugs

Nilo Therapeutics
Mapping the brain-body axis to achieve proper immune balance